日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 Trial

阿贝拉西单抗与利伐沙班治疗老年房颤患者:AZALEA-TIMI 71 2b 期试验的预设分析

Al Said, Samer; Patel, Siddharth M; Giugliano, Robert P; Morrow, David A; Goodrich, Erica L; Murphy, Sabina A; Hug, Bruce; Parkar, Sanobar; Chen, Shih-Ann; Goodman, Shaun G; Joung, Boyoung; Kiss, Robert G; Wojakowski, Wojciech; Weitz, Jeffrey I; Bloomfield, Dan; Sabatine, Marc S; Ruff, Christian T

Considerations for the Adoption of Digital Algorithms and Cardiovascular Decision-Support Tools in Clinical Practice

临床实践中采用数字算法和心血管决策支持工具的考量

Baugh, Christopher W; Gibson, C Michael; Giannitsis, Evangelos; Morrow, David A; Januzzi, James L; Papendick, Cynthia; Brunner-La Rocca, Hans-Peter; Daniels, Lori B; Palau, Helena; Visciola, Ludovica; Than, Martin

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial

阿贝拉西单抗与利伐沙班治疗接受抗血小板治疗的房颤患者:AZALEA-TIMI 71试验的预设分析

Al Said, Samer; Patel, Siddharth M; Giugliano, Robert P; Morrow, David A; Goodrich, Erica L; Murphy, Sabina A; Hug, Bruce; Parkar, Sanobar; Chen, Shih-Ann; Goodman, Shaun G; Joung, Boyoung; Kiss, Robert G; Wojakowski, Wojciech; Weitz, Jeffrey I; Bloomfield, Dan; Sabatine, Marc S; Ruff, Christian T

Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71

长效因子XI抑制剂与围手术期出血:来自AZALEA-TIMI 71研究的分析

Patel, Siddharth M; Giugliano, Robert P; Morrow, David A; Parkar, Sanobar; Shapiro, Hannah; Hug, Bruce; Kuder, Julia F; Goodrich, Erica L; Chen, Shih-Ann; Goodman, Shaun G; Joung, Boyoung; Kiss, Robert G; Wojakowski, Wojciech; Weitz, Jeffrey I; Murphy, Sabina A; Wiviott, Stephen D; Bloomfield, Daniel; Sabatine, Marc S; Ruff, Christian T

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

肾功能对使用阿贝拉西单抗抑制因子XI治疗房颤的安全性影响:AZALEA-TIMI 71随机临床试验的预设分析

Patel, Siddharth M; Giugliano, Robert P; Morrow, David A; Goodrich, Erica L; Murphy, Sabina A; Hug, Bruce; Parkar, Sanobar; Chen, Shih-Ann; Goodman, Shaun G; Joung, Boyoung; Kiss, Robert G; Wojakowski, Wojciech; Weitz, Jeffrey I; Bloomfield, Dan; Sabatine, Marc S; Ruff, Christian T

Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical Trial

利用现有心血管数据改进高血压的检测和治疗:NOTIFY-LVH随机临床试验

Berman, Adam N; Hidrue, Michael K; Ginder, Curtis; Shirkey, Linnea; Kwatra, Japneet; O'Kelly, Anna C; Murphy, Sean P; Searl Como, Jennifer M; Daly, Danielle; Sun, Yee-Ping; Curry, William T; Del Carmen, Marcela G; Blankstein, Ron; Dodson, John A; Morrow, David A; Scirica, Benjamin M; Choudhry, Niteesh K; Januzzi, James L Jr; Wasfy, Jason H

Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical Trial

细胞粘附分子与慢性心力衰竭不良结局:DAPA-HF随机临床试验的研究结果

McDowell, Kirsty; Welsh, Paul; Docherty, Kieran F; Morrow, David A; Jhund, Pardeep S; De Boer, Rudolf A; O'Meara, Eileen; Inzucchi, Silvio E; Køber, Lars; Kosiborod, Mikhail N; Martinez, Felipe A; Ponikowski, Piotr; Hammarstedt, Ann; Langkilde, Anna Maria; Solomon, Scott D; Sattar, Naveed; Sabatine, Marc S; McMurray, John J V

Sacubitril/valsartan versus valsartan initiation in patients naïve to renin-angiotensin system inhibitors: Insights from PARAGLIDE-HF

在未接受过肾素-血管紧张素系统抑制剂治疗的患者中,沙库巴曲/缬沙坦与缬沙坦单药治疗的疗效比较:来自PARAGLIDE-HF研究的启示

Nouhravesh, Nina; Gunn, Alexander H; Cyr, Derek; Hernandez, Adrian F; Morrow, David A; Velazquez, Eric J; Ward, Jonathan H; Sarwat, Samiha; Sharma, Kavita; Williamson, Kristin M; Starling, Randall C; Lepage, Serge; Zieroth, Shelley; Solomon, Scott D; Mentz, Robert J

Epidemiology and Prognostic Significance of Acute Noncardiac Organ Dysfunction Across Cardiogenic Shock Subtypes

心源性休克亚型中急性非心脏器官功能障碍的流行病学和预后意义

Varshney, Anubodh S; Palazzolo, Michael G; Barnett, Christopher F; Bohula, Erin A; Burke, James A; Chaudhry, Sunit-Preet; Chonde, Meshe D; Ghafghazi, Shahab; Gerber, Daniel A; Kenigsberg, Benjamin; Kontos, Michael C; Kwon, Younghoon; Lawler, Patrick R; Loriaux, Daniel B; Menon, Venu; Miller, P Elliott; O'Brien, Connor G; Papolos, Alexander I; Patel, Siddharth M; Potter, Brian J; Prasad, Rajnish; Shah, Kevin S; Sinha, Shashank S; Solomon, Michael A; Thompson, Andrea; Teuteberg, Jeffrey J; VAN Diepen, Sean; Morrow, David A; Berg, David D

In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial

在心力衰竭恶化事件后,轻度射血分数降低或保留的患者中,院内或院外启动沙库巴曲/缬沙坦与缬沙坦治疗的比较:PARAGLIDE-HF 试验

Nouhravesh, Nina; Cyr, Derek; Hernandez, Adrian F; Morrow, David A; Velazquez, Eric J; Ward, Jonathan; Sarwat, Samiha; Sharma, Kavita; Williamson, Kristin; Starling, Randall C; Lepage, Serge; Zieroth, Shelley; Solomon, Scott D; Mentz, Robert J